As a progressive, irreversible neurodegenerative disease, Alzheimer's disease (AD)
continues to be a serious public health problem worldwide. Currently, the most available …

Alzheimer's disease (AD) is one of the main causes of dementia worldwide, whereby
neuronal death or malfunction leads to cognitive impairment in the elderly population. AD is …

Alzheimer's disease (AD) remains an incurable disease and lacks efficient diagnostic
methods. Most AD treatments have focused on amyloid-β (Aβ) targeted therapy; however, it …

The main factors of Alzheimer's disease (AD) are the cerebral accumulation and the
formation of extracellular amyloid plaques. The Aβ peptides are highly able to accumulative …

Nanocarriers provide a platform to integrate therapy and diagnostics, which is an emerging
direction in medical practice. Beyond simply therapeutic functionality, theranostic …

Nanoscale structures have been at the core of research efforts dealing with integration of
nanotechnology into novel electronic devices for the last decade. Because the size of …

The emergence of nanocarrier systems in drug delivery applications has ushered in rapid
development of new classes of therapeutic agents which can provide an essential …

Prevention and therapeutic strategies for various neurodegenerative diseases focus on
inhibiting protein fibrillation, clearing aggregated protein plaques from the brain, and …

Aggregation of amyloid β-protein (Aβ) into amyloid oligomers and fibrils is pathologically
linked to Alzheimer's disease (AD). Hence, the inhibition of Aβ aggregation is essential for …

Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …